US Patent 11634475 Therapeutic variant alpha-2-macroglobulin compositions
Patent 11634475 was granted and assigned to Cytonics Corporation on April, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 3, 2020
0
Date of Patent
April 25, 2023
0
Patent Applicant
Patent Application Number
17110766
0
Patent Inventor Names
Shawn Robert Browning
0
John David Laughlin
0
Lewis Hanna
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11634475 Therapeutic variant alpha-2-macroglobulin compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
